«Modern therapy of mental disorders» 2017, №1 [Sovrem. ter. psih. rasstrojstv]

«Modern therapy of mental disorders» 2017, №1 [Sovrem. ter. psih. rasstrojstv]

Pharmacogenetic approach to increase efficacy and safety of schizophrenia treatment with antipsychotics

A.O. Kibitov, D.V. Ivashchenko, D.A. Sychev

Influence of the number of CYP2D6 active alleles on the antipsychotic daily doses, hospital duration and safety in psychiatric in-patients population

A.A. Kurylev, V.M. Brodyansky, B.V. Andreev, A.O. Kibitov

14

Tardive dyskinesia: advances of modern pharmacogenetics

O.Yu. Fedorenko, S.A. Ivanova, A.V. Semke, N.A. Bokhan

22

Therapeutic drug monitoring of clozapine and norclozapine in schizophrenia

N.V. Baymeeva, L.M. Krasnykh, V.G. Kaleda, E.R. Nikolaeva, S.A. Ivanova, I.I. Miroshnichenko1

29

Paliperidone Palmitate 3-Month Formulation (Trevicta) – a new word for the longterm therapy of patients with schizophrenia

Oleneva E.V., Ryvkin P.V., Ladyzhensky M.Ya.

35

Intramuscular Ziprasidone: experience and potential for use in psychiatry

V.E. Medvedev, T.S. Syunyakov

45

Download PDF